Categories
Life Sciences Consumer Goods Materials and Chemicals Construction & Manufacturing Food and Beverages Energy and Power Semiconductor and Electronics Automotive and Transportation ICT & Media Aerospace & Defense BFSI

Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com

MRI Compatible IV Infusion Pumps Market by Product Type (Pumps, Tubing and Disposables) and by End User (Hospitals, Ambulatory Surgical Centers (ASCs), Diagnostics and Imaging Centers): Global Opportunity Analysis and Industry Forecast, 2023-2032

A04145

Pages: NA

Charts: NA

Tables: NA

Infusion pumps are the medical devices that deliver fluids in particular doses into the patients body. These are employed to inject fluids such as nutrients and medications. MRI compatible IV infusion pumps provides safe and accurate delivery of intravenous fluids during and after an MRI scan.

Rise in prevalence of life threatening diseases, high demand of MRI diagnostics, growth in geriatric population, and increase in hospitalization of patients drive the market. However, factors such as high cost of devices and lack of awareness about the procedure restrain the market growth. The development of advanced IV infusion pump systems and untapped markets provide numerous opportunities for the market growth.

MRI compatible IV infusion pumps market is segmented on the basis of product type, end user, and region. On the basis of product type, the market is bifurcated into pumps, and tubing & disposables. Pumps can be further sub-segmented into infusion and IV pumps. Infusion pumps can be segmented as, magnetic and non-magnetic pump system and IV pumps as peristal IV pumps, and piston driven pumps. Based on end user, the market is divided into hospitals, ambulatory surgical centers, and diagnostics & imaging centers. By geography, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The key players operating in this market include B. Braun Melsungen AG, IRadimed Corporation, Arcomed AG, Fresenius SE & Co. KGaA, Becton, Dickinson and Company, Baxter International Inc., Medtronic Plc., Smiths Group plc, F. Hoffmann-La Roche AG, and Kimberly-Clark Health Care.

Key Benefits

  • The study provides an in-depth analysis of the global MRI compatible IV infusion pumps market with current trends and future estimations to elucidate the imminent investment pockets.
  • The report provides information about the current and upcoming trends in the market which helps to determine the prevailing opportunities.
  • Comprehensive analysis of factors that drive and restrict the growth of the market is provided.
  • Identification of factors instrumental in changing the market scenario, rise in opportunities, and identification of key companies that can influence this market on a global and regional scale are provided.
  • Key market players are profiled and their strategies are analyzed thoroughly, which elucidate the competitive outlook of the market.

 Key Market Segments

  • By Product Type
    • Pumps
    • Tubing and Disposables
  • By End User
    • Hospitals
    • Ambulatory Surgical Centers (ASCs)
    • Diagnostics and Imaging Centers
  • By Region
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • France
      • Germany
      • Italy
      • Spain
      • UK
      • Rest of Europe
    • Asia-Pacific
      • China
      • Japan
      • India
      • South Korea
      • Australia
      • Rest of Asia-Pacific
    • LAMEA
      • Brazil
      • South Africa
      • Saudi Arabia
      • Rest of LAMEA

 
Key Market Players

  • Medtronic Plc.
  • F. Hoffmann-La Roche AG
  • IRadimed Corporation
  • Smiths Group plc
  • Becton Dickinson and Company
  • Arcomed AG
  • Fresenius SE & Co. KGaA
  • Baxter International Inc.
  • B. Braun Melsungen AG
  • Kimberly-Clark Health Care.

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

  • CHAPTER 4: MRI COMPATIBLE IV INFUSION PUMPS MARKET, BY PRODUCT TYPE

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Product Type

    • 4.2. Pumps

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Tubing And Disposables

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

  • CHAPTER 5: MRI COMPATIBLE IV INFUSION PUMPS MARKET, BY END USER

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By End User

    • 5.2. Hospitals

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Ambulatory Surgical Centers (ASCs)

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. Diagnostics And Imaging Centers

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

  • CHAPTER 6: MRI COMPATIBLE IV INFUSION PUMPS MARKET, BY REGION

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By Region

    • 6.2. North America

      • 6.2.1. Key Market Trends and Opportunities

      • 6.2.2. Market Size and Forecast, By Product Type

      • 6.2.3. Market Size and Forecast, By End User

      • 6.2.4. Market Size and Forecast, By Country

      • 6.2.5. U.S. Mri Compatible Iv Infusion Pumps Market

        • 6.2.5.1. Market Size and Forecast, By Product Type
        • 6.2.5.2. Market Size and Forecast, By End User

      • 6.2.6. Canada Mri Compatible Iv Infusion Pumps Market

        • 6.2.6.1. Market Size and Forecast, By Product Type
        • 6.2.6.2. Market Size and Forecast, By End User

      • 6.2.7. Mexico Mri Compatible Iv Infusion Pumps Market

        • 6.2.7.1. Market Size and Forecast, By Product Type
        • 6.2.7.2. Market Size and Forecast, By End User

    • 6.3. Europe

      • 6.3.1. Key Market Trends and Opportunities

      • 6.3.2. Market Size and Forecast, By Product Type

      • 6.3.3. Market Size and Forecast, By End User

      • 6.3.4. Market Size and Forecast, By Country

      • 6.3.5. France Mri Compatible Iv Infusion Pumps Market

        • 6.3.5.1. Market Size and Forecast, By Product Type
        • 6.3.5.2. Market Size and Forecast, By End User

      • 6.3.6. Germany Mri Compatible Iv Infusion Pumps Market

        • 6.3.6.1. Market Size and Forecast, By Product Type
        • 6.3.6.2. Market Size and Forecast, By End User

      • 6.3.7. Italy Mri Compatible Iv Infusion Pumps Market

        • 6.3.7.1. Market Size and Forecast, By Product Type
        • 6.3.7.2. Market Size and Forecast, By End User

      • 6.3.8. Spain Mri Compatible Iv Infusion Pumps Market

        • 6.3.8.1. Market Size and Forecast, By Product Type
        • 6.3.8.2. Market Size and Forecast, By End User

      • 6.3.9. UK Mri Compatible Iv Infusion Pumps Market

        • 6.3.9.1. Market Size and Forecast, By Product Type
        • 6.3.9.2. Market Size and Forecast, By End User

      • 6.3.10. Russia Mri Compatible Iv Infusion Pumps Market

        • 6.3.10.1. Market Size and Forecast, By Product Type
        • 6.3.10.2. Market Size and Forecast, By End User

      • 6.3.11. Rest Of Europe Mri Compatible Iv Infusion Pumps Market

        • 6.3.11.1. Market Size and Forecast, By Product Type
        • 6.3.11.2. Market Size and Forecast, By End User

    • 6.4. Asia-Pacific

      • 6.4.1. Key Market Trends and Opportunities

      • 6.4.2. Market Size and Forecast, By Product Type

      • 6.4.3. Market Size and Forecast, By End User

      • 6.4.4. Market Size and Forecast, By Country

      • 6.4.5. China Mri Compatible Iv Infusion Pumps Market

        • 6.4.5.1. Market Size and Forecast, By Product Type
        • 6.4.5.2. Market Size and Forecast, By End User

      • 6.4.6. Japan Mri Compatible Iv Infusion Pumps Market

        • 6.4.6.1. Market Size and Forecast, By Product Type
        • 6.4.6.2. Market Size and Forecast, By End User

      • 6.4.7. India Mri Compatible Iv Infusion Pumps Market

        • 6.4.7.1. Market Size and Forecast, By Product Type
        • 6.4.7.2. Market Size and Forecast, By End User

      • 6.4.8. South Korea Mri Compatible Iv Infusion Pumps Market

        • 6.4.8.1. Market Size and Forecast, By Product Type
        • 6.4.8.2. Market Size and Forecast, By End User

      • 6.4.9. Australia Mri Compatible Iv Infusion Pumps Market

        • 6.4.9.1. Market Size and Forecast, By Product Type
        • 6.4.9.2. Market Size and Forecast, By End User

      • 6.4.10. Thailand Mri Compatible Iv Infusion Pumps Market

        • 6.4.10.1. Market Size and Forecast, By Product Type
        • 6.4.10.2. Market Size and Forecast, By End User

      • 6.4.11. Malaysia Mri Compatible Iv Infusion Pumps Market

        • 6.4.11.1. Market Size and Forecast, By Product Type
        • 6.4.11.2. Market Size and Forecast, By End User

      • 6.4.12. Indonesia Mri Compatible Iv Infusion Pumps Market

        • 6.4.12.1. Market Size and Forecast, By Product Type
        • 6.4.12.2. Market Size and Forecast, By End User

      • 6.4.13. Rest of Asia Pacific Mri Compatible Iv Infusion Pumps Market

        • 6.4.13.1. Market Size and Forecast, By Product Type
        • 6.4.13.2. Market Size and Forecast, By End User

    • 6.5. LAMEA

      • 6.5.1. Key Market Trends and Opportunities

      • 6.5.2. Market Size and Forecast, By Product Type

      • 6.5.3. Market Size and Forecast, By End User

      • 6.5.4. Market Size and Forecast, By Country

      • 6.5.5. Brazil Mri Compatible Iv Infusion Pumps Market

        • 6.5.5.1. Market Size and Forecast, By Product Type
        • 6.5.5.2. Market Size and Forecast, By End User

      • 6.5.6. South Africa Mri Compatible Iv Infusion Pumps Market

        • 6.5.6.1. Market Size and Forecast, By Product Type
        • 6.5.6.2. Market Size and Forecast, By End User

      • 6.5.7. Saudi Arabia Mri Compatible Iv Infusion Pumps Market

        • 6.5.7.1. Market Size and Forecast, By Product Type
        • 6.5.7.2. Market Size and Forecast, By End User

      • 6.5.8. UAE Mri Compatible Iv Infusion Pumps Market

        • 6.5.8.1. Market Size and Forecast, By Product Type
        • 6.5.8.2. Market Size and Forecast, By End User

      • 6.5.9. Argentina Mri Compatible Iv Infusion Pumps Market

        • 6.5.9.1. Market Size and Forecast, By Product Type
        • 6.5.9.2. Market Size and Forecast, By End User

      • 6.5.10. Rest of LAMEA Mri Compatible Iv Infusion Pumps Market

        • 6.5.10.1. Market Size and Forecast, By Product Type
        • 6.5.10.2. Market Size and Forecast, By End User

  • CHAPTER 7: COMPETITIVE LANDSCAPE

    • 7.1. Introduction

    • 7.2. Top Winning Strategies

    • 7.3. Product Mapping Of Top 10 Player

    • 7.4. Competitive Dashboard

    • 7.5. Competitive Heatmap

    • 7.6. Top Player Positioning, 2024

  • CHAPTER 8: COMPANY PROFILES

    • 8.1. B. Braun Melsungen AG

      • 8.1.1. Company Overview

      • 8.1.2. Key Executives

      • 8.1.3. Company Snapshot

      • 8.1.4. Operating Business Segments

      • 8.1.5. Product Portfolio

      • 8.1.6. Business Performance

      • 8.1.7. Key Strategic Moves and Developments

    • 8.2. IRadimed Corporation

      • 8.2.1. Company Overview

      • 8.2.2. Key Executives

      • 8.2.3. Company Snapshot

      • 8.2.4. Operating Business Segments

      • 8.2.5. Product Portfolio

      • 8.2.6. Business Performance

      • 8.2.7. Key Strategic Moves and Developments

    • 8.3. Arcomed AG

      • 8.3.1. Company Overview

      • 8.3.2. Key Executives

      • 8.3.3. Company Snapshot

      • 8.3.4. Operating Business Segments

      • 8.3.5. Product Portfolio

      • 8.3.6. Business Performance

      • 8.3.7. Key Strategic Moves and Developments

    • 8.4. Fresenius SE And Co. KGaA

      • 8.4.1. Company Overview

      • 8.4.2. Key Executives

      • 8.4.3. Company Snapshot

      • 8.4.4. Operating Business Segments

      • 8.4.5. Product Portfolio

      • 8.4.6. Business Performance

      • 8.4.7. Key Strategic Moves and Developments

    • 8.5. Becton Dickinson And Company

      • 8.5.1. Company Overview

      • 8.5.2. Key Executives

      • 8.5.3. Company Snapshot

      • 8.5.4. Operating Business Segments

      • 8.5.5. Product Portfolio

      • 8.5.6. Business Performance

      • 8.5.7. Key Strategic Moves and Developments

    • 8.6. Baxter International Inc.

      • 8.6.1. Company Overview

      • 8.6.2. Key Executives

      • 8.6.3. Company Snapshot

      • 8.6.4. Operating Business Segments

      • 8.6.5. Product Portfolio

      • 8.6.6. Business Performance

      • 8.6.7. Key Strategic Moves and Developments

    • 8.7. Medtronic Plc.

      • 8.7.1. Company Overview

      • 8.7.2. Key Executives

      • 8.7.3. Company Snapshot

      • 8.7.4. Operating Business Segments

      • 8.7.5. Product Portfolio

      • 8.7.6. Business Performance

      • 8.7.7. Key Strategic Moves and Developments

    • 8.8. Smiths Group Plc

      • 8.8.1. Company Overview

      • 8.8.2. Key Executives

      • 8.8.3. Company Snapshot

      • 8.8.4. Operating Business Segments

      • 8.8.5. Product Portfolio

      • 8.8.6. Business Performance

      • 8.8.7. Key Strategic Moves and Developments

    • 8.9. F. Hoffmann-La Roche AG

      • 8.9.1. Company Overview

      • 8.9.2. Key Executives

      • 8.9.3. Company Snapshot

      • 8.9.4. Operating Business Segments

      • 8.9.5. Product Portfolio

      • 8.9.6. Business Performance

      • 8.9.7. Key Strategic Moves and Developments

    • 8.10. Kimberly-Clark Health Care.

      • 8.10.1. Company Overview

      • 8.10.2. Key Executives

      • 8.10.3. Company Snapshot

      • 8.10.4. Operating Business Segments

      • 8.10.5. Product Portfolio

      • 8.10.6. Business Performance

      • 8.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL MRI COMPATIBLE IV INFUSION PUMPS MARKET, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 2. GLOBAL MRI COMPATIBLE IV INFUSION PUMPS MARKET FOR PUMPS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 3. GLOBAL MRI COMPATIBLE IV INFUSION PUMPS MARKET FOR TUBING AND DISPOSABLES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 4. GLOBAL MRI COMPATIBLE IV INFUSION PUMPS MARKET, BY END USER, 2025-2033 ($MILLION)
  • TABLE 5. GLOBAL MRI COMPATIBLE IV INFUSION PUMPS MARKET FOR HOSPITALS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 6. GLOBAL MRI COMPATIBLE IV INFUSION PUMPS MARKET FOR AMBULATORY SURGICAL CENTERS (ASCS), BY REGION, 2025-2033 ($MILLION)
  • TABLE 7. GLOBAL MRI COMPATIBLE IV INFUSION PUMPS MARKET FOR DIAGNOSTICS AND IMAGING CENTERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 8. GLOBAL MRI COMPATIBLE IV INFUSION PUMPS MARKET, BY REGION, 2025-2033 ($MILLION)
  • TABLE 9. NORTH AMERICA MRI COMPATIBLE IV INFUSION PUMPS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 10. NORTH AMERICA MRI COMPATIBLE IV INFUSION PUMPS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 11. NORTH AMERICA MRI COMPATIBLE IV INFUSION PUMPS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 12. U.S. MRI COMPATIBLE IV INFUSION PUMPS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 13. U.S. MRI COMPATIBLE IV INFUSION PUMPS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 14. CANADA MRI COMPATIBLE IV INFUSION PUMPS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 15. CANADA MRI COMPATIBLE IV INFUSION PUMPS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 16. MEXICO MRI COMPATIBLE IV INFUSION PUMPS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 17. MEXICO MRI COMPATIBLE IV INFUSION PUMPS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 18. EUROPE MRI COMPATIBLE IV INFUSION PUMPS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 19. EUROPE MRI COMPATIBLE IV INFUSION PUMPS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 20. EUROPE MRI COMPATIBLE IV INFUSION PUMPS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 21. FRANCE MRI COMPATIBLE IV INFUSION PUMPS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 22. FRANCE MRI COMPATIBLE IV INFUSION PUMPS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 23. GERMANY MRI COMPATIBLE IV INFUSION PUMPS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 24. GERMANY MRI COMPATIBLE IV INFUSION PUMPS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 25. ITALY MRI COMPATIBLE IV INFUSION PUMPS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 26. ITALY MRI COMPATIBLE IV INFUSION PUMPS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 27. SPAIN MRI COMPATIBLE IV INFUSION PUMPS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 28. SPAIN MRI COMPATIBLE IV INFUSION PUMPS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 29. UK MRI COMPATIBLE IV INFUSION PUMPS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 30. UK MRI COMPATIBLE IV INFUSION PUMPS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 31. RUSSIA MRI COMPATIBLE IV INFUSION PUMPS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 32. RUSSIA MRI COMPATIBLE IV INFUSION PUMPS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 33. REST OF EUROPE MRI COMPATIBLE IV INFUSION PUMPS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 34. REST OF EUROPE MRI COMPATIBLE IV INFUSION PUMPS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 35. ASIA-PACIFIC MRI COMPATIBLE IV INFUSION PUMPS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 36. ASIA-PACIFIC MRI COMPATIBLE IV INFUSION PUMPS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 37. ASIA-PACIFIC MRI COMPATIBLE IV INFUSION PUMPS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 38. CHINA MRI COMPATIBLE IV INFUSION PUMPS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 39. CHINA MRI COMPATIBLE IV INFUSION PUMPS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 40. JAPAN MRI COMPATIBLE IV INFUSION PUMPS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 41. JAPAN MRI COMPATIBLE IV INFUSION PUMPS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 42. INDIA MRI COMPATIBLE IV INFUSION PUMPS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 43. INDIA MRI COMPATIBLE IV INFUSION PUMPS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 44. SOUTH KOREA MRI COMPATIBLE IV INFUSION PUMPS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 45. SOUTH KOREA MRI COMPATIBLE IV INFUSION PUMPS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 46. AUSTRALIA MRI COMPATIBLE IV INFUSION PUMPS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 47. AUSTRALIA MRI COMPATIBLE IV INFUSION PUMPS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 48. THAILAND MRI COMPATIBLE IV INFUSION PUMPS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 49. THAILAND MRI COMPATIBLE IV INFUSION PUMPS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 50. MALAYSIA MRI COMPATIBLE IV INFUSION PUMPS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 51. MALAYSIA MRI COMPATIBLE IV INFUSION PUMPS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 52. INDONESIA MRI COMPATIBLE IV INFUSION PUMPS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 53. INDONESIA MRI COMPATIBLE IV INFUSION PUMPS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 54. REST OF ASIA PACIFIC MRI COMPATIBLE IV INFUSION PUMPS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 55. REST OF ASIA PACIFIC MRI COMPATIBLE IV INFUSION PUMPS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 56. LAMEA MRI COMPATIBLE IV INFUSION PUMPS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 57. LAMEA MRI COMPATIBLE IV INFUSION PUMPS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 58. LAMEA MRI COMPATIBLE IV INFUSION PUMPS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 59. BRAZIL MRI COMPATIBLE IV INFUSION PUMPS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 60. BRAZIL MRI COMPATIBLE IV INFUSION PUMPS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 61. SOUTH AFRICA MRI COMPATIBLE IV INFUSION PUMPS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 62. SOUTH AFRICA MRI COMPATIBLE IV INFUSION PUMPS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 63. SAUDI ARABIA MRI COMPATIBLE IV INFUSION PUMPS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 64. SAUDI ARABIA MRI COMPATIBLE IV INFUSION PUMPS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 65. UAE MRI COMPATIBLE IV INFUSION PUMPS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 66. UAE MRI COMPATIBLE IV INFUSION PUMPS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 67. ARGENTINA MRI COMPATIBLE IV INFUSION PUMPS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 68. ARGENTINA MRI COMPATIBLE IV INFUSION PUMPS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 69. REST OF LAMEA MRI COMPATIBLE IV INFUSION PUMPS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 70. REST OF LAMEA MRI COMPATIBLE IV INFUSION PUMPS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 71. B. BRAUN MELSUNGEN AG: KEY EXECUTIVES
  • TABLE 72. B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT
  • TABLE 73. B. BRAUN MELSUNGEN AG: OPERATING SEGMENTS
  • TABLE 74. B. BRAUN MELSUNGEN AG: PRODUCT PORTFOLIO
  • TABLE 75. B. BRAUN MELSUNGEN AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 76. IRADIMED CORPORATION: KEY EXECUTIVES
  • TABLE 77. IRADIMED CORPORATION: COMPANY SNAPSHOT
  • TABLE 78. IRADIMED CORPORATION: OPERATING SEGMENTS
  • TABLE 79. IRADIMED CORPORATION: PRODUCT PORTFOLIO
  • TABLE 80. IRADIMED CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 81. ARCOMED AG: KEY EXECUTIVES
  • TABLE 82. ARCOMED AG: COMPANY SNAPSHOT
  • TABLE 83. ARCOMED AG: OPERATING SEGMENTS
  • TABLE 84. ARCOMED AG: PRODUCT PORTFOLIO
  • TABLE 85. ARCOMED AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 86. FRESENIUS SE AND CO. KGAA: KEY EXECUTIVES
  • TABLE 87. FRESENIUS SE AND CO. KGAA: COMPANY SNAPSHOT
  • TABLE 88. FRESENIUS SE AND CO. KGAA: OPERATING SEGMENTS
  • TABLE 89. FRESENIUS SE AND CO. KGAA: PRODUCT PORTFOLIO
  • TABLE 90. FRESENIUS SE AND CO. KGAA: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 91. BECTON DICKINSON AND COMPANY: KEY EXECUTIVES
  • TABLE 92. BECTON DICKINSON AND COMPANY: COMPANY SNAPSHOT
  • TABLE 93. BECTON DICKINSON AND COMPANY: OPERATING SEGMENTS
  • TABLE 94. BECTON DICKINSON AND COMPANY: PRODUCT PORTFOLIO
  • TABLE 95. BECTON DICKINSON AND COMPANY: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 96. BAXTER INTERNATIONAL INC.: KEY EXECUTIVES
  • TABLE 97. BAXTER INTERNATIONAL INC.: COMPANY SNAPSHOT
  • TABLE 98. BAXTER INTERNATIONAL INC.: OPERATING SEGMENTS
  • TABLE 99. BAXTER INTERNATIONAL INC.: PRODUCT PORTFOLIO
  • TABLE 100. BAXTER INTERNATIONAL INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 101. MEDTRONIC PLC.: KEY EXECUTIVES
  • TABLE 102. MEDTRONIC PLC.: COMPANY SNAPSHOT
  • TABLE 103. MEDTRONIC PLC.: OPERATING SEGMENTS
  • TABLE 104. MEDTRONIC PLC.: PRODUCT PORTFOLIO
  • TABLE 105. MEDTRONIC PLC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 106. SMITHS GROUP PLC: KEY EXECUTIVES
  • TABLE 107. SMITHS GROUP PLC: COMPANY SNAPSHOT
  • TABLE 108. SMITHS GROUP PLC: OPERATING SEGMENTS
  • TABLE 109. SMITHS GROUP PLC: PRODUCT PORTFOLIO
  • TABLE 110. SMITHS GROUP PLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 111. F. HOFFMANN-LA ROCHE AG: KEY EXECUTIVES
  • TABLE 112. F. HOFFMANN-LA ROCHE AG: COMPANY SNAPSHOT
  • TABLE 113. F. HOFFMANN-LA ROCHE AG: OPERATING SEGMENTS
  • TABLE 114. F. HOFFMANN-LA ROCHE AG: PRODUCT PORTFOLIO
  • TABLE 115. F. HOFFMANN-LA ROCHE AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 116. KIMBERLY-CLARK HEALTH CARE.: KEY EXECUTIVES
  • TABLE 117. KIMBERLY-CLARK HEALTH CARE.: COMPANY SNAPSHOT
  • TABLE 118. KIMBERLY-CLARK HEALTH CARE.: OPERATING SEGMENTS
  • TABLE 119. KIMBERLY-CLARK HEALTH CARE.: PRODUCT PORTFOLIO
  • TABLE 120. KIMBERLY-CLARK HEALTH CARE.: KEY STRATEGIC MOVES AND DEVELOPMENTS

  • LIST OF FIGURES

  • FIGURE 1. GLOBAL MRI COMPATIBLE IV INFUSION PUMPS MARKET SEGMENTATION
  • FIGURE 2. GLOBAL MRI COMPATIBLE IV INFUSION PUMPS MARKET
  • FIGURE 3. SEGMENTATION MRI COMPATIBLE IV INFUSION PUMPS MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN MRI COMPATIBLE IV INFUSION PUMPS MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALMRI COMPATIBLE IV INFUSION PUMPS MARKET
  • FIGURE 11. MRI COMPATIBLE IV INFUSION PUMPS MARKET SEGMENTATION, BY BY PRODUCT TYPE
  • FIGURE 12. MRI COMPATIBLE IV INFUSION PUMPS MARKET FOR PUMPS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 13. MRI COMPATIBLE IV INFUSION PUMPS MARKET FOR TUBING AND DISPOSABLES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 14. MRI COMPATIBLE IV INFUSION PUMPS MARKET SEGMENTATION, BY BY END USER
  • FIGURE 15. MRI COMPATIBLE IV INFUSION PUMPS MARKET FOR HOSPITALS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 16. MRI COMPATIBLE IV INFUSION PUMPS MARKET FOR AMBULATORY SURGICAL CENTERS (ASCS), BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 17. MRI COMPATIBLE IV INFUSION PUMPS MARKET FOR DIAGNOSTICS AND IMAGING CENTERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 18. TOP WINNING STRATEGIES, BY YEAR, 2022-2024*
  • FIGURE 19. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2022-2024*
  • FIGURE 20. TOP WINNING STRATEGIES, BY COMPANY, 2022-2024*
  • FIGURE 21. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 22. COMPETITIVE DASHBOARD
  • FIGURE 23. COMPETITIVE HEATMAP: MRI COMPATIBLE IV INFUSION PUMPS MARKET
  • FIGURE 24. TOP PLAYER POSITIONING, 2024
  • FIGURE 25. B. BRAUN MELSUNGEN AG: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 26. B. BRAUN MELSUNGEN AG: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 27. B. BRAUN MELSUNGEN AG: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 28. IRADIMED CORPORATION: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 29. IRADIMED CORPORATION: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 30. IRADIMED CORPORATION: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 31. ARCOMED AG: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 32. ARCOMED AG: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 33. ARCOMED AG: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 34. FRESENIUS SE AND CO. KGAA: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 35. FRESENIUS SE AND CO. KGAA: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 36. FRESENIUS SE AND CO. KGAA: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 37. BECTON DICKINSON AND COMPANY: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 38. BECTON DICKINSON AND COMPANY: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 39. BECTON DICKINSON AND COMPANY: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 40. BAXTER INTERNATIONAL INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 41. BAXTER INTERNATIONAL INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 42. BAXTER INTERNATIONAL INC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 43. MEDTRONIC PLC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 44. MEDTRONIC PLC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 45. MEDTRONIC PLC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 46. SMITHS GROUP PLC: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 47. SMITHS GROUP PLC: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 48. SMITHS GROUP PLC: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 49. F. HOFFMANN-LA ROCHE AG: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 50. F. HOFFMANN-LA ROCHE AG: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 51. F. HOFFMANN-LA ROCHE AG: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 52. KIMBERLY-CLARK HEALTH CARE.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 53. KIMBERLY-CLARK HEALTH CARE.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 54. KIMBERLY-CLARK HEALTH CARE.: REVENUE SHARE, BY REGION, 2024 (%)

Purchase Full Report of
MRI Compatible IV Infusion Pumps Market

PURCHASE OPTIONS



* Taxes/Fees, If applicable will be added during checkout. All prices in USD.

Have a question ?

Need to add more ?

Avail up to 30% discount on subscription plans on


Avenue

© 2025 Allied Market Research. All Rights Reserved